Emergency Medicine · Toxicology
The facts most likely to be tested
Elapid snakes, including coral snakes, possess neurotoxic venom that causes presynaptic and postsynaptic neuromuscular blockade.
The classic mnemonic for North American coral snake identification is 'Red on yellow, kill a fellow; red on black, friend of Jack'.
Clinical presentation is characterized by minimal local tissue reaction at the bite site, often masking the severity of the systemic envenomation.
The hallmark systemic manifestation is descending flaccid paralysis, beginning with ptosis, diplopia, and dysphagia.
Severe envenomation leads to respiratory failure due to diaphragmatic paralysis, which is the primary cause of mortality.
The definitive treatment for symptomatic patients is the administration of specific antivenom (e.g., North American Coral Snake Antivenom).
Patients must be monitored for a minimum of 24 hours due to the potential for delayed onset of respiratory symptoms.
Vignette unlocked
A 28-year-old hiker presents to the emergency department after being bitten on the hand while moving rocks. He describes the snake as having red, yellow, and black rings. On physical exam, there is minimal swelling or erythema at the bite site. Two hours later, the patient develops bilateral ptosis, dysarthria, and difficulty swallowing. His oxygen saturation begins to drop, and he appears to have weakness in his accessory muscles of respiration.
What is the most appropriate next step in management?
Administration of coral snake antivenom and endotracheal intubation
The patient exhibits classic signs of neurotoxic elapid envenomation; because the venom causes progressive respiratory paralysis, immediate antivenom and airway protection are required.
Full handout
High yield triage
Etiology / Epidemiology
Caused by neurotoxic venom from snakes like coral snakes; risk is highest in southeastern US during warm months.
Clinical Manifestations
Presents with descending paralysis and bulbar palsies; often lacks significant local tissue destruction.
Diagnosis
Diagnosis is clinical; monitor negative inspiratory force (NIF) and vital capacity for respiratory failure.
Treatment
Immediate antivenom administration is the only definitive therapy; do not delay for symptom onset.
Prognosis
High risk of respiratory failure; requires prolonged observation for up to 24 hours.
Full handout
Epidemiology & Etiology
Elapid envenomation primarily involves the Micrurus fulvius (Eastern Coral Snake) in the US. Bites typically occur when individuals attempt to handle or capture snakes. Most cases are concentrated in the southeastern United States.
Pertinent Anatomy
Elapids possess fixed, short, proteroglyphous fangs located at the front of the maxilla. Unlike vipers, they lack heat-sensing pits and have round pupils. Their anatomy necessitates a chewing motion to effectively deliver venom.
Pathophysiology
Venom contains potent alpha-neurotoxins that bind irreversibly to postsynaptic acetylcholine receptors at the neuromuscular junction. This prevents depolarization, leading to progressive muscle weakness. The process is often delayed, with systemic symptoms appearing hours after the bite.
Clinical Manifestations
Initial local findings are often minimal, characterized by fang marks without significant edema. Systemic progression includes ptosis, diplopia, and dysphagia. Respiratory failure is the primary cause of mortality, often preceded by diaphragmatic paralysis.
Diagnosis
Diagnosis is strictly clinical based on bite history and neurological progression. No specific lab test confirms envenomation. Serial monitoring of negative inspiratory force (NIF) and vital capacity is mandatory to detect impending respiratory collapse.
Treatment
The North American Coral Snake Antivenom is the definitive treatment. Do not wait for symptoms to appear if a confirmed bite occurred. Prophylactic administration is indicated due to the high risk of rapid, irreversible paralysis. Supportive care includes mechanical ventilation if respiratory parameters decline.
Prognosis
Prognosis is excellent if antivenom is administered early. Patients must be observed for at least 24 hours due to the potential for delayed onset of neurotoxicity. Respiratory failure is the most critical complication requiring ICU admission.
Differential Diagnosis
Crotalid envenomation: characterized by significant local tissue necrosis and coagulopathy
Botulism: presents with similar descending paralysis but lacks a bite history
Myasthenia gravis: chronic course with diurnal variation in weakness
Tick paralysis: ascending rather than descending paralysis
Guillain-Barré syndrome: typically follows a viral prodrome with ascending weakness